Cao X - Search Results

1

Recent progress of SRC family kinase inhibitors as anticancer agents.

Cao X, You QD, Li ZY, Wang XJ, Lu XY, Liu XR, Xu D, Liu B. Cao X, et al. Mini Rev Med Chem. 2008 Sep;8(10):1053-63. doi: 10.2174/138955708785740634. Mini Rev Med Chem. 2008. PMID: 18782057 Review.

2

Design and synthesis of 7-alkoxy-4-heteroarylamino-3-quinolinecarbonitriles as dual inhibitors of c-Src kinase and nitric oxide synthase.

Cao X, You QD, Li ZY, Guo QL, Shang J, Yan M, Chern JW, Chen ML. Cao X, et al. Bioorg Med Chem. 2008 Jun 1;16(11):5890-8. doi: 10.1016/j.bmc.2008.04.065. Epub 2008 Apr 29. Bioorg Med Chem. 2008. PMID: 18485715

3

The design, synthesis and biological evaluation of 7-alkoxy-4-heteroarylamino-3-cyanoquinolines as dual inhibitors of c-Src and iNOS.

Cao X, You QD, Li ZY, Liu XR, Xu D, Guo QL, Shang J, Chern JW, Chen ML. Cao X, et al. Bioorg Med Chem Lett. 2008 Dec 1;18(23):6206-9. doi: 10.1016/j.bmcl.2008.10.006. Epub 2008 Oct 5. Bioorg Med Chem Lett. 2008. PMID: 18930653

4

[The design, synthesis and anticancer activity of 4-heteroarylamino-3-cyanoquinolines as dual inhibitors of c-Src and iNOS].

Cao X, You QD, Li ZY, Guo QL, Yang Y, Shang J, Yan M, Chen JW, Chen ML. Cao X, et al. Yao Xue Xue Bao. 2009 Mar;44(3):288-95. Yao Xue Xue Bao. 2009. PMID: 19449526 Chinese.

5

Recent progress of Src SH2 and SH3 inhibitors as anticancer agents.

Lu XL, Cao X, Liu XY, Jiao BH. Lu XL, et al. Among authors: cao x. Curr Med Chem. 2010;17(12):1117-24. doi: 10.2174/092986710790827861. Curr Med Chem. 2010. PMID: 20158477 Review.

6

Novel patented SRC kinase inhibitor.

Lu XL, Liu XY, Cao X, Jiao BH. Lu XL, et al. Among authors: cao x. Curr Med Chem. 2012;19(12):1821-9. doi: 10.2174/092986712800099802. Curr Med Chem. 2012. PMID: 22414081 Review.

7

A brief perspective of drug resistance toward EGFR inhibitors: the crystal structures of EGFRs and their variants.

Guan H, Du Y, Ning Y, Cao X. Guan H, et al. Among authors: cao x. Future Med Chem. 2017 May;9(7):693-704. doi: 10.4155/fmc-2016-0222. Epub 2017 May 15. Future Med Chem. 2017. PMID: 28504890 Review.

8

VISTA inhibitors in cancer immunotherapy: a short perspective on recent progresses.

Wu C, Cao X, Zhang X. Wu C, et al. Among authors: cao x. RSC Med Chem. 2021 Jul 6;12(10):1672-1679. doi: 10.1039/d1md00185j. eCollection 2021 Oct 20. RSC Med Chem. 2021. PMID: 34778768 Free PMC article. Review.

9

Marine Antibody-Drug Conjugates: Design Strategies and Research Progress.

Wang YJ, Li YY, Liu XY, Lu XL, Cao X, Jiao BH. Wang YJ, et al. Among authors: cao x. Mar Drugs. 2017 Jan 13;15(1):18. doi: 10.3390/md15010018. Mar Drugs. 2017. PMID: 28098746 Free PMC article. Review.

10

AcGlcAs: A Novel P53-Targeting Arsenical with Potent Cellular Uptake and Cancer Cell Selectivity.

Liang Y, An Q, Song H, Tang Y, Xiao S, Wu J, Yan N, Yu B, Cao X, Lu M. Liang Y, et al. Among authors: cao x. J Med Chem. 2023 Dec 28;66(24):16579-16596. doi: 10.1021/acs.jmedchem.3c00104. Epub 2023 Dec 9. J Med Chem. 2023. PMID: 38069817

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16,941 results

Search Page

Filters